Lexaria Bioscience Corp (LXX.CN)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [CNSX]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 08/31
| 07-2012 | 04-2012 | 01-2012 | 10-2011 | 07-2011 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 16 | 121 | 140 | 31 | 494 |
| Receivables | 498 | 140 | 176 | 231 | 232 |
| TOTAL | $517 | $265 | $323 | $264 | $730 |
| Non-Current Assets | |||||
| PPE Net | 3,707 | 3,818 | 3,857 | 4,042 | 3,135 |
| Other Non-Current Assets | 0 | 49 | 49 | 33 | 0 |
| TOTAL | $3,707 | $3,867 | $3,906 | $4,075 | $3,135 |
| Total Assets | $4,224 | $4,131 | $4,228 | $4,339 | $3,865 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 1,652 | 1,612 | 1,553 | 755 | 783 |
| Accounts payable and accrued liabilities | 182 | 197 | 122 | 322 | 92 |
| TOTAL | $1,836 | $1,811 | $1,676 | $1,079 | $877 |
| Non-Current Liabilities | |||||
| Long Term Debt | N/A | N/A | N/A | 599 | 599 |
| TOTAL | $0 | $0 | $0 | $599 | $599 |
| Total Liabilities | $1,836 | $1,811 | $1,676 | $1,678 | $1,476 |
| Shareholders' Equity | |||||
| Common Shares | 16 | 16 | 16 | 16 | 16 |
| Retained earnings | -4,746 | -4,814 | -4,582 | -4,463 | -4,463 |
| TOTAL | $2,388 | $2,320 | $2,552 | $2,661 | $2,389 |
| Total Liabilities And Equity | $4,224 | $4,131 | $4,228 | $4,339 | $3,865 |